Compare BioNTech SE - ADR (BNTX) vs Citigroup Inc. (C) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Citigroup Inc. — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Citigroup Inc. trades at $135.95 (market cap $227.75B). The key difference: Citigroup Inc. is far larger — about 9.8× BioNTech SE - ADR's market cap, and Citigroup Inc. pays a 1.97% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | C | |
|---|---|---|
Market Cap | $23.31B | $227.75B |
Sector | Health | Financials |
52-Week High | $119.34 | $145.67 |
52-Week Low | $83.89 | $92.59 |
Enterprise Value | $6.60B | — |
Dividend Yield | — | 1.97% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Citigroup Inc.
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →
